About Us
Bastion Therapeutics is a preclinical stage biotechnology company leveraging proprietary platform technology to engineer Tregs to modulate the immune system and overcome challenges associated with previous generations of Treg cell therapy
Vision
Our vision for the future is to become a global leader in the field of inflammatory disorders, transforming lives with our pioneering therapies.
We aim to grow as a biotech hub of scientific excellence, providing curative treatments for patients suffering from inflammatory disorders.
We are committed to addressing the gender disparity seen in autoimmune diseases and partnering with other innovators to accelerate new therapies from the clinic to the patients.
Through innovation and collaboration, we will shape a future where these debilitating conditions are effectively managed and ultimately cured.
Mission
Our mission goes beyond making small improvements; we aim to lead a profound revolution in treating inflammatory disorders.
We are driven by a deep belief in the transformative potential of Tregs to regulate the immune system, reduce excessive inflammation, and promote tissue healing.
Our goal is to develop pioneering, best-in-class Treg therapies that address the root causes of these disorders, providing long-term relief for patients suffering from inflammatory diseases.
Purpose
Our purpose is to cultivate an extraordinary environment that serves as a sanctuary for curious minds, a crucible for trailblazing scientific discoveries, and a haven where innovation flourishes.
We understand that the key to transformative discoveries lies in the collective brilliance and diverse perspectives of our team members.
We foster a culture that not only embraces but also celebrates diversity and inclusivity, recognising that it is the mosaic of unique backgrounds, experiences, and talents that fuels our collective growth and propels us towards greatness.
